Aurinia: 2Q Earnings Snapshot
VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Tuesday reported a loss of $15.9 million in its second quarter.
On a per-share basis, the Victoria, British Columbia-based company said it had a loss of 17 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.
The biotechnology company posted revenue of $29,000 in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $53,000.
Aurinia shares have dropped 12% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $6.02, a climb of 14% in the last 12 months.